A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent-Reference-Cited by-同舟云学术

A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent

Published:2018-05-23 Issue:442 Volume:10 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Gioelli Noemi¹²^ORCID,Maione Federica²³^ORCID,Camillo Chiara¹²^ORCID,Ghitti Michela⁴^ORCID,Valdembri Donatella¹²^ORCID,Morello Noemi⁵^ORCID,Darche Marie⁶,Zentilin Lorena⁷,Cagnoni Gabriella¹²,Qiu Yaqi²³,Giacca Mauro⁷^ORCID,Giustetto Maurizio⁵⁸^ORCID,Paques Michel⁹¹⁰,Cascone Ilaria⁶,Musco Giovanna⁴^ORCID,Tamagnone Luca¹²,Giraudo Enrico²³^ORCID,Serini Guido¹²^ORCID

Affiliation:

1. Department of Oncology, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy.

2. Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Torino, Italy.

3. Department of Science and Drug Technology, University of Torino, 10125 Torino, Italy.

4. Biomolecular NMR Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.

5. Department of Neuroscience, University of Torino School of Medicine, 10126 Torino, Italy.

6. Growth, Reparation and Tissue Regeneration Laboratory, ERL-CNRS 9215, University of Paris-Est, 94000 Créteil, France.

7. Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology, 34149 Trieste, Italy.

8. National Institute of Neuroscience-Italy, 10126 Torino, Italy.

9. Vision Institute, Sorbonne University, UPMC University of Paris 06, INSERM, CNRS, 75012 Paris, France.

10. Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, INSERM-DHOS CIC 503, 75012 Paris, France.

Abstract

An NRP1-independent, non-natural SEMA3A mutant isoform is a parenterally deliverable anticancer drug that normalizes the vasculature.

Funder

Swiss National Science Foundation

Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Fondazione Piemontese per la Ricerca sul Cancro - ONLUS

Associazione ‘Augusto per la Vita’

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference89 articles.

1. Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

2. Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression

3. Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors

4. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment

5. Hypoxia and the extracellular matrix: drivers of tumour metastasis

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment;Frontiers in Immunology;2024-02-05

2. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening;Journal of Experimental & Clinical Cancer Research;2024-01-10

3. Alleviating hypoxia to improve cancer immunotherapy;Oncogene;2023-10-26

4. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening;2023-10-09

5. Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer;Trends in Molecular Medicine;2023-10